Company intelligence / Profile preview

Focal Biosciences

Villigen, Aargau, Switzerlandfocalbiosciences.com ↗

Ownership: Private
Development stage: Preclinical

Overview

Focal Biosciences is developing a proprietary AI-driven platform to identify small molecule drugs that can epigenetically reprogram cells from diseased or aged states back to healthy states. The company’s approach leverages advanced imaging, mechanobiology, and machine learning in physiologically relevant 3D assays. Their immediate focus is on fibrotic diseases with plans to expand into broader age-related conditions. As of early 2024, the company is preclinical and preparing its first compound screens.[1][2][3][4][5]

Therapeutic areas: Other
Modalities: Small molecules (epigenetic modulators)[5]Potentially other modalities related to cellular reprogramming, but primarily small molecules[5]
Industry: Biotech

Partnerships

Apollo Health Ventures (venture creation/investor/partner)[4]Paul Scherrer Institute (PSI) – scientific collaboration/facilities access/incubation partner[4]ETH Zurich – research collaboration in high-throughput screening/mechanogenomics [4][5]

Beyond the preview

Go deeper on Focal Biosciences.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Focal Biosciences.

Explore the full profile